SCHEMBL2669153

SCHEMBL2669153

CCCCCCC(Cc1ccc(-c2ccc(C(C)(C)C)cc2)cc1)c1ccc(C(=O)NCCC(=O)O)cc1C

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GCGR P47871 17/20 0.53
ADCY6 O43306 5/20 0.51
ADCY3 O60266 5/20 0.51
ADCY9 O60503 5/20 0.51
ADCY5 O95622 5/20 0.51
ADCY8 P40145 5/20 0.51
ADCY7 P51828 5/20 0.51
ADCY2 Q08462 5/20 0.51
ADCY1 Q08828 5/20 0.51
ADCY4 Q8NFM4 5/20 0.51
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ESRRG P62508 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657077 0.87 GCGR (0.60) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2658990 0.79 GCGR (0.51) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2656673 0.79 MEN1 (0.52) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL21528960 0.77 GCGR (0.60) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL21528961 0.77 GCGR (0.60) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL1765472 0.76 GCGR (0.57) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2654861 0.76 GCGR (0.61) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2658181 0.74 GCGR (0.53) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL1765376 0.74 GCGR (0.73) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2657984 0.74 GCGR (0.64) GCGRADCY6ADCY3ADCY9ADCY5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007123581-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed